# Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.

> **NCT00770653** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 305 (actual)

## Conditions studied

- Diabetes Mellitus
- Dyslipidemias

## Interventions

- **DRUG:** Pioglitazone and Metformin
- **DRUG:** Glimepiride and Metformin

## Key facts

- **NCT ID:** NCT00770653
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2010-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770653, "Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.". Retrieved via AI Analytics 2026-07-21 from https://api.ai-analytics.org/clinical/NCT00770653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*